IDEXX Laboratories Stock

IDEXX Laboratories EBIT

The EBIT of IDEXX Laboratories (IDXX) as of Aug 15, 2026 is 1.36 B USD. In the previous year, EBIT was 1.13 B USD — a change of 20.53% (higher).

EBIT

1.36 BUSD

YoY

20.53%

Last updated:

In 2026, IDEXX Laboratories's EBIT was 1.36 B USD, a 20.53% increase from the 1.13 B USD EBIT recorded in the previous year.

The IDEXX Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B USD)
Date
EBIT (B USD)
Jan 1, 2023
1.10 base
Jan 1, 2024
1.13 base
Jan 1, 2025
1.36 base
Jan 1, 2026 (e)
1.39 base
Jan 1, 2027 (e)
1.51 base
Jan 1, 2028 (e)
1.64 base
Jan 1, 2029 (e)
1.80 base
Jan 1, 2030 (e)
2.05 base
YEAREBIT (B USD)
2030 est 2.05
2029 est 1.80
2028 est 1.64
2027 est 1.51
2026 est 1.39
2025 1.36
2024 1.13
2023 1.10
2022 0.90
2021 0.93
2020 0.69
2019 0.55
2018 0.49
2017 0.41
2016 0.35
2015 0.30
2014 0.26
2013 0.27
2012 0.26
2011 0.24
2010 0.20
2009 0.18
2008 0.17
2007 0.14
2006 0.13
Access this data via the Eulerpool API

IDEXX Laboratories Revenue

IDEXX Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
3.66 B USD
1.10 B USD
845.04 M USD
Jan 1, 2024
3.90 B USD
1.13 B USD
887.87 M USD
Jan 1, 2025
4.30 B USD
1.36 B USD
1.06 B USD
Jan 1, 2026 (e)
4.72 B USD
1.39 B USD
1.20 B USD
Jan 1, 2027 (e)
5.14 B USD
1.51 B USD
1.36 B USD
Jan 1, 2028 (e)
5.59 B USD
1.64 B USD
1.52 B USD
Jan 1, 2029 (e)
6.13 B USD
1.80 B USD
1.74 B USD
Jan 1, 2030 (e)
6.98 B USD
2.05 B USD
2.11 B USD

IDEXX Laboratories Margins

IDEXX Laboratories stock margins

The IDEXX Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IDEXX Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IDEXX Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
59.82 %
29.97 %
23.08 %
Jan 1, 2024
61.04 %
28.95 %
22.78 %
Jan 1, 2025
61.80 %
31.60 %
24.62 %
Jan 1, 2026 (e)
61.80 %
29.32 %
25.44 %
Jan 1, 2027 (e)
61.80 %
29.30 %
26.39 %
Jan 1, 2028 (e)
61.80 %
29.41 %
27.19 %
Jan 1, 2029 (e)
61.80 %
29.41 %
28.39 %
Jan 1, 2030 (e)
61.80 %
29.41 %
30.29 %

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing IDEXX Laboratories's EBIT

IDEXX Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of IDEXX Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

IDEXX Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in IDEXX Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about IDEXX Laboratories stock

EBIT of IDEXX Laboratories is 1.36 B USD in 2026.

EBIT of IDEXX Laboratories changed from 1.13 B USD to 1.36 B USD, representing a 20.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's IDEXX Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — IDEXX Laboratories

All Key Metrics — IDEXX Laboratories